We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA included detailed recommendations for booster shot studies in a final guidance on Emergency Use Authorizations (EUAs) for COVID-19 vaccines released yesterday. Read More
Akebia Therapeutics will have to conduct a new clinical trial if it wants to move its kidney disease drug vadadustat forward, the FDA said in a Complete Response Letter (CRL) denying approval for the investigational drug. Read More
Clovis Oncology’s Rubraca (Rucaparib) nearly halved the risk of disease progression in women with newly diagnosed advanced ovarian cancer following treatment combined with platinum-based chemotherapy. Read More
AbbVie’s Allergan subsidiary and Teva Pharmaceuticals have agreed to pay nearly $330 million to settle claims that they played a role in the opioid abuse and overdose crisis in Florida. Read More
The Department of Justice (DOJ) is reportedly investigating a large prescription drug-trafficking network that allegedly has and is selling hundreds of millions of dollars of counterfeit HIV medications. Read More
Antares acquired exclusive rights to Tlando from Salt Lake City, Utah-based Lipocine in October 2021 as part of a $21 million licensing deal. Read More
The FDA has accused a Polish company that manufactures and sells over-the-counter (OTC) products online of making a homeopathic drug cream that contains 100 million times the active concentration that the drug is purported to possess on its label. Read More